Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

10.1182/blood-2013-06-511592

Saved in:

Bibliographic Details
Main Authors:	Jabbour, E., Kantarjian, H.M., Saglio, G., Steegmann, J.L., Shah, N.P., Boqué, C., Chuah, C., Pavlovsky, C., Mayer, J., Cortes, J., Baccarani, M., Kim, D.-W., Bradley-Garelik, M.B., Mohamed, H., Wildgust, M., Hochhaus, A.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/128648
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-128648
record_format	dspace
spelling	sg-nus-scholar.10635-1286482023-10-30T07:22:00Z Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION) Jabbour, E. Kantarjian, H.M. Saglio, G. Steegmann, J.L. Shah, N.P. Boqué, C. Chuah, C. Pavlovsky, C. Mayer, J. Cortes, J. Baccarani, M. Kim, D.-W. Bradley-Garelik, M.B. Mohamed, H. Wildgust, M. Hochhaus, A. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE 10.1182/blood-2013-06-511592 Blood 123 4 494-500 BLOOA 2016-10-19T08:43:36Z 2016-10-19T08:43:36Z 2014-01-23 Article Jabbour, E., Kantarjian, H.M., Saglio, G., Steegmann, J.L., Shah, N.P., Boqué, C., Chuah, C., Pavlovsky, C., Mayer, J., Cortes, J., Baccarani, M., Kim, D.-W., Bradley-Garelik, M.B., Mohamed, H., Wildgust, M., Hochhaus, A. (2014-01-23). Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). Blood 123 (4) : 494-500. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2013-06-511592 00064971 http://scholarbank.nus.edu.sg/handle/10635/128648 000334254200013 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1182/blood-2013-06-511592
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Jabbour, E. Kantarjian, H.M. Saglio, G. Steegmann, J.L. Shah, N.P. Boqué, C. Chuah, C. Pavlovsky, C. Mayer, J. Cortes, J. Baccarani, M. Kim, D.-W. Bradley-Garelik, M.B. Mohamed, H. Wildgust, M. Hochhaus, A.
format	Article
author	Jabbour, E. Kantarjian, H.M. Saglio, G. Steegmann, J.L. Shah, N.P. Boqué, C. Chuah, C. Pavlovsky, C. Mayer, J. Cortes, J. Baccarani, M. Kim, D.-W. Bradley-Garelik, M.B. Mohamed, H. Wildgust, M. Hochhaus, A.
spellingShingle	Jabbour, E. Kantarjian, H.M. Saglio, G. Steegmann, J.L. Shah, N.P. Boqué, C. Chuah, C. Pavlovsky, C. Mayer, J. Cortes, J. Baccarani, M. Kim, D.-W. Bradley-Garelik, M.B. Mohamed, H. Wildgust, M. Hochhaus, A. Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
author_sort	Jabbour, E.
title	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
title_short	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
title_full	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
title_fullStr	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
title_full_unstemmed	Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
title_sort	early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (dasision)
publishDate	2016
url	http://scholarbank.nus.edu.sg/handle/10635/128648
_version_	1781790587289075712

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

Similar Items